Dasan
Group
About Us
Culture
History
Partners
Contact Us
Business
R&D
Import
Clinical
MAH
Healthy
Technology
Platform
Achievements
Equipment
Products
Drugs
Supplements
Cosmetics
News
Industry
Company
Careers
Philosophy
Job
Activities
Benefits
ADR Reporting
ADR Reporting
Korean
Korean
English
Dasan
Group
About Us
Culture
History
Partners
Contact Us
Business
R&D
Import
Clinical
MAH
Healthy
Technology
Platform
Achievements
Equipment
Products
Drugs
Supplements
Cosmetics
News
Industry
Company
Careers
Philosophy
Job
Activities
Benefits
ADR Reporting
ADR Reporting
CN
|
EN
News
Follow us for R&D updates, partnerships, and industry insights.
Home
News
Dasan
Business
Technology
Products
News
Careers
ADR Reporting
Industry
Industry
Company
Industry
A New Option for Formulation Optimization: Application of Mini-Tablets
Differences Between Two Common Antiallergic Drugs: Cetirizine and Loratadine
Oral Semaglutide Is Here! The Weight-Loss Drug Boom Is Sizzling Hot!
How to choose between domestic generic drugs that have passed the consistency evaluation and original (imported) drugs?
Distinguish
Title
Data
Market Analysis
MAHA Report: The Child Chronic Disease Crisis
2025-05-30
Drug Knowledge
The impact of sleep duration on health
2025-01-21
Drug Knowledge
Drinking Water During Meals: Is It Good or Bad?
2024-12-10
Drug Knowledge
How to Quickly Relieve Nasal Congestion During the Autumn-Winter Transition?
2024-11-28
Market Analysis
The uric acid levels of Chinese people are rising rapidly.
2024-10-08
Drug Knowledge
A New Choice for Combination Lipid-Lowering — Rosuvastatin and Ezetimibe Tablets (I)
2024-08-27
Drug Knowledge
A New Option for Formulation Optimization: Application of Mini-Tablets
2024-07-29
Drug Knowledge
Caffeine in Milk Tea: Surprisingly High Content
2024-07-03
Drug Knowledge
Unveiling the Mystery of Blister Pack Packaging
2024-05-28
Drug Knowledge
Differences Between Two Common Antiallergic Drugs: Cetirizine and Loratadine
2024-04-30
Drug Knowledge
What You Need to Know About “Disease X”
2024-03-15
Industry Trends
CDE Issues Overseas Drug Re-Registration Guidelines — 120-Day Approval
2025-10-31
Home
Previous
1
2
3
Next
Last